Lv6
2140 积分 2023-09-18 加入
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial
12天前
已完结
Efficacy and safety of anlotinib-based chemotherapy for locally advanced or metastatic anaplastic thyroid carcinoma
12天前
已完结
Real-world efficacy and safety of ritlecitinib in alopecia areata: A single-centre experience
4个月前
已完结
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial
4个月前
已完结
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial
4个月前
已完结
Global, regional and national epidemiology of alopecia areata: a systematic review and modelling study
4个月前
已完结
Adjuvant lenvatinib after radical resection in patients with hepatocellular carcinoma (HCC): preliminary analysis of a prospective, multi‐center, single‐arm study
6个月前
已完结
Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy
6个月前
已完结
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
6个月前
已完结
Transcatheter arterial infusion of anti-programmed cell death 1 antibody pembrolizumab combined with temozolomide or nab-paclitaxel in patient with primary anorectal malignant melanoma: Four case reports
6个月前
已完结
皖公网安备34019202002308
